Skip to Main Content

Paper Details

Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
Cancer
0
2024
1-Mb window, CpGs, DNA, DNA methylation markers, NSCLC, TRK fusion proteins, genes, larotrectinib, lung cancer, methylation markers, non-small cell, non-small cell lung cancer, patients, sarcomas
Author NameAffiliation
Demetrius AlbanesNational Cancer Institute
Maria Teresa LandiNational Cancer Institute
Angela RischAllergy-Cancer-BioNano Research Centre, University of Salzburg
Angela RischDKFZ-German Cancer Research Center
Angela RischTranslational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL)
H-Erich WichmannInstitute of Epidemiology
Heike Bickeb??llerUniversity Medical Center Goettingen
John K FieldMolecular and Clinical Cancer Medicine, The University of Liverpool Institute of Translational Medicine
Loic Le MarchandUniversity of Hawai'i Cancer Center
Rayjean J HungLunenfeld-Tanenbaum Research Institute
Lambertus A KiemeneyRadboud University Medical Center
Neil E CaporasoNational Cancer Institute
Neil E CaporasoNational Cancer Institute
Christopher I AmosBaylor College of Medicine, Institute for Clinical and Translational Research
Christopher I AmosBaylor College of Medicine, Institute for Clinical and Translational Research
  • 1 - 15

Datasets

Release 1.2